265 related articles for article (PubMed ID: 34143825)
1. Predictive functional analysis reveals inferred features unique to cervicovaginal microbiota of African women with bacterial vaginosis and high-risk human papillomavirus infection.
Onywera H; Anejo-Okopi J; Mwapagha LM; Okendo J; Williamson AL
PLoS One; 2021; 16(6):e0253218. PubMed ID: 34143825
[TBL] [Abstract][Full Text] [Related]
2. Cervicovaginal microbiome and natural history of HPV in a longitudinal study.
Usyk M; Zolnik CP; Castle PE; Porras C; Herrero R; Gradissimo A; Gonzalez P; Safaeian M; Schiffman M; Burk RD;
PLoS Pathog; 2020 Mar; 16(3):e1008376. PubMed ID: 32214382
[TBL] [Abstract][Full Text] [Related]
3. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with the composition and diversity of the cervical microbiota of reproductive-age Black South African women: a retrospective cross-sectional study.
Onywera H; Williamson AL; Mbulawa ZZA; Coetzee D; Meiring TL
PeerJ; 2019; 7():e7488. PubMed ID: 31435492
[TBL] [Abstract][Full Text] [Related]
5. The vaginal microbiota among the different status of human papillomavirus infection and bacterial vaginosis.
Liu Y; Li T; Guo R; Chen T; Wang S; Wu D; Li J; Liu Z; Zhao Y; Yin J; Qin J; Sun L; Chen W
J Med Virol; 2023 Mar; 95(3):e28595. PubMed ID: 36811337
[TBL] [Abstract][Full Text] [Related]
6. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD
J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection.
Di Paola M; Sani C; Clemente AM; Iossa A; Perissi E; Castronovo G; Tanturli M; Rivero D; Cozzolino F; Cavalieri D; Carozzi F; De Filippo C; Torcia MG
Sci Rep; 2017 Aug; 7(1):10200. PubMed ID: 28860468
[TBL] [Abstract][Full Text] [Related]
8. The cervical microbiota in reproductive-age South African women with and without human papillomavirus infection.
Onywera H; Williamson AL; Mbulawa ZZA; Coetzee D; Meiring TL
Papillomavirus Res; 2019 Jun; 7():154-163. PubMed ID: 30986570
[TBL] [Abstract][Full Text] [Related]
9. The cervical microbiota of Hispanics living in Puerto Rico is nonoptimal regardless of HPV status.
Vargas-Robles D; Romaguera J; Alvarado-Velez I; Tosado-Rodríguez E; Dominicci-Maura A; Sanchez M; Wiggin KJ; Martinez-Ferrer M; Gilbert JA; Forney LJ; Godoy-Vitorino F
mSystems; 2023 Aug; 8(4):e0035723. PubMed ID: 37534938
[TBL] [Abstract][Full Text] [Related]
10. The Cervicovaginal Microbiota in Women Notified for Chlamydia trachomatis Infection: A Case-Control Study at the Sexually Transmitted Infection Outpatient Clinic in Amsterdam, The Netherlands.
van der Veer C; Bruisten SM; van der Helm JJ; de Vries HJ; van Houdt R
Clin Infect Dis; 2017 Jan; 64(1):24-31. PubMed ID: 27567124
[TBL] [Abstract][Full Text] [Related]
11. Diversity of cervicovaginal microbiota associated with female lower genital tract infections.
Ling Z; Liu X; Chen X; Zhu H; Nelson KE; Xia Y; Li L; Xiang C
Microb Ecol; 2011 Apr; 61(3):704-14. PubMed ID: 21287345
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women.
Borgdorff H; Tsivtsivadze E; Verhelst R; Marzorati M; Jurriaans S; Ndayisaba GF; Schuren FH; van de Wijgert JH
ISME J; 2014 Sep; 8(9):1781-93. PubMed ID: 24599071
[TBL] [Abstract][Full Text] [Related]
13. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
Pramanick R; Mayadeo N; Warke H; Begum S; Aich P; Aranha C
Microb Pathog; 2019 Sep; 134():103599. PubMed ID: 31212037
[TBL] [Abstract][Full Text] [Related]
14. Vaginal flora in HPV infection: a cross‑sectional analysis.
Dou P; Fang F; Qin R; Nie J; Chen X; Yin X; Wang Y; Shi S
J Obstet Gynaecol; 2024 Dec; 44(1):2361847. PubMed ID: 38861397
[TBL] [Abstract][Full Text] [Related]
15. Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array.
Taku O; Onywera H; Mbulawa ZZA; Businge CB; Meiring TL; Williamson AL
Microbiol Spectr; 2022 Jun; 10(3):e0222921. PubMed ID: 35647888
[TBL] [Abstract][Full Text] [Related]
16. Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia.
Shipitsyna E; Khusnutdinova T; Budilovskaya O; Krysanova A; Shalepo K; Savicheva A; Unemo M
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1221-1230. PubMed ID: 32036466
[TBL] [Abstract][Full Text] [Related]
17. Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity.
Dols JA; Molenaar D; van der Helm JJ; Caspers MP; de Kat Angelino-Bart A; Schuren FH; Speksnijder AG; Westerhoff HV; Richardus JH; Boon ME; Reid G; de Vries HJ; Kort R
BMC Infect Dis; 2016 Apr; 16():180. PubMed ID: 27107961
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterisation of vaginal lactobacilli from South African women.
Pendharkar S; Magopane T; Larsson PG; de Bruyn G; Gray GE; Hammarström L; Marcotte H
BMC Infect Dis; 2013 Jan; 13():43. PubMed ID: 23351177
[TBL] [Abstract][Full Text] [Related]
19. Cervical microbiota dysbiosis associated with high-risk Human Papillomavirus infection.
Zeber-Lubecka N; Kulecka M; Dabrowska M; Baginska-Drabiuk K; Glowienka-Stodolak M; Nowakowski A; Slabuszewska-Jozwiak A; Bednorz B; Jędrzejewska I; Piasecka M; Pawelec J; Wojciechowska-Lampka E; Ostrowski J
PLoS One; 2024; 19(4):e0302270. PubMed ID: 38669258
[TBL] [Abstract][Full Text] [Related]
20. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
